Skip to content

Evommune EVMN Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin53.7%+1.0pp52.7%-3.3pp55.9%+0.7pp55.2%
Operating margin-30.7%-9.6pp-21.2%-15.2pp-5.9%+2.4pp-8.3%
Efficiency
Inventory turnover3.6×+1.7×1.9×-1.6×3.5×
Liquidity
Current ratio1.2×+0.3×0.9×+0.2×0.7×
Quick ratio0.6×0.0×0.6×+0.2×0.4×
Cash ratio0.4×-0.1×0.5×+0.3×0.2×
Leverage
Debt-to-assets0.3×0.0×0.2×0.0×0.2×
Interest coverage-6.2×-2.7×-3.5×-2.6×-0.9×+0.6×-1.4×
Per Share
Book value per share-$0.23-1,372%$0.02-78.5%$0.08$0.02+225%
Valuation
Market capitalization$848.59M+42.8%$539.69M
Enterprise value$849.52M$539.07M
Price / sales127.3×81.6×
EV / sales130.5×81.5×

Questions, answered.

What are Evommune 's profit margins?
Evommune (EVMN) runs a 53.7% gross margin and a -30.7% operating margin, with a -90.1% net margin.
Where do Evommune 's ratios come from?
Every ratio is computed from Evommune 's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.